Difference between revisions of "Team:Virginia/New parts"

 
(25 intermediate revisions by the same user not shown)
Line 1: Line 1:
−
<html><head>
+
<html><head></head><body>
 +
 
 
     <meta charset="utf-8"/>
 
     <meta charset="utf-8"/>
 
     <meta content="width=device-width" name="viewport"/>
 
     <meta content="width=device-width" name="viewport"/>
Line 26: Line 27:
 
     <!---------------------------------------------------------->
 
     <!---------------------------------------------------------->
  
−
   </head>
+
    
−
   <body>
+
    
 
     <!--headerstart-->
 
     <!--headerstart-->
 
     <div class="topnavholder">
 
     <div class="topnavholder">
Line 35: Line 36:
 
         <div class="topnav">
 
         <div class="topnav">
 
           <div class="dropdown">
 
           <div class="dropdown">
−
             <a class="active mainitem" href="#home">HOME</a>
+
             <a class="mainitem" href="https://2020.igem.org/Team:Virginia">HOME</a>
 
             <div class="dropdown-content">
 
             <div class="dropdown-content">
−
               <a class="hvr-sweep-to-right" href="index.html#">Main</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia">Main</a>
−
               <a class="hvr-sweep-to-right" href="index.html#abstract">Abstract</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia#abstract">Abstract</a>
−
              <a class="hvr-sweep-to-right" href="index.html#problem">Problem</a>
+
−
              <a class="hvr-sweep-to-right" href="index.html#solution">Solution</a>
+
 
             </div>
 
             </div>
 
           </div>
 
           </div>
Line 46: Line 45:
 
             <a class="mainitem" href="#project">PROJECT</a>
 
             <a class="mainitem" href="#project">PROJECT</a>
 
             <div class="dropdown-content">
 
             <div class="dropdown-content">
−
               <a class="hvr-sweep-to-right" href="#">Inspiration</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Description">Description</a>
−
               <a class="hvr-sweep-to-right" href="#">Description</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Design">Design</a>
−
               <a class="hvr-sweep-to-right" href="#">Design</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Experiments">Experiments</a>
−
               <a class="hvr-sweep-to-right" href="#">Experiments</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Results">Results</a>
−
               <a class="hvr-sweep-to-right" href="#">Results</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Model">Modeling</a>
−
               <a class="hvr-sweep-to-right" href="#">Modeling</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Engineering">Engineering</a>
−
               <a class="hvr-sweep-to-right" href="#">Device</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Implementation">Implementation</a>
−
               <a class="hvr-sweep-to-right" href="#">Notebook</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Notebook">Notebook</a>
−
               <a class="hvr-sweep-to-right" href="#">Safety</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Safety">Safety</a>
 
             </div>
 
             </div>
 
           </div>
 
           </div>
Line 60: Line 59:
 
             <a class="mainitem" href="#parts">PARTS</a>
 
             <a class="mainitem" href="#parts">PARTS</a>
 
             <div class="dropdown-content">
 
             <div class="dropdown-content">
−
               <a class="hvr-sweep-to-right" href="#">New Parts</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/New_parts"> Parts</a>
−
              <a class="hvr-sweep-to-right" href="#">Utilized Parts</a>
+
 
             </div>
 
             </div>
 
           </div>
 
           </div>
Line 67: Line 65:
 
             <a class="mainitem" href="#outreach">OUTREACH</a>
 
             <a class="mainitem" href="#outreach">OUTREACH</a>
 
             <div class="dropdown-content">
 
             <div class="dropdown-content">
−
               <a class="hvr-sweep-to-right" href="#">Human Practices</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Human_Practices">Human Practices</a>
−
               <a class="hvr-sweep-to-right" href="#">Public Engagement</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Public_engagement">Public Engagement</a>
−
               <a class="hvr-sweep-to-right" href="#">Collaborations</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Collaborations">Collaborations</a>
−
               <a class="hvr-sweep-to-right" href="#">Meet Ups</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Contribution">Contributions</a>
 +
              <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Entrepreneurship">Entrepreneurship</a>
 
             </div>
 
             </div>
 
           </div>
 
           </div>
Line 77: Line 76:
 
             <div class="dropdown-content">
 
             <div class="dropdown-content">
 
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Members">Members</a>
 
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Members">Members</a>
−
               <a class="hvr-sweep-to-right" href="#">Attributions</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Attributions">Attributions</a>
−
              <a class="hvr-sweep-to-right" href="#">Gallery</a>
+
 
             </div>
 
             </div>
 
           </div>
 
           </div>
Line 84: Line 82:
 
             <a class="mainitem" href="#awards">AWARDS</a>
 
             <a class="mainitem" href="#awards">AWARDS</a>
 
             <div class="dropdown-content">
 
             <div class="dropdown-content">
−
               <a class="hvr-sweep-to-right" href="#">Awards</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Awards">Awards</a>
−
               <a class="hvr-sweep-to-right" href="#">Medals</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Medals">Medals</a>
 
             </div>
 
             </div>
 
           </div>
 
           </div>
Line 91: Line 89:
 
             <a class="mainitem" href="#about">RESOURCES</a>
 
             <a class="mainitem" href="#about">RESOURCES</a>
 
             <div class="dropdown-content">
 
             <div class="dropdown-content">
−
               <a class="hvr-sweep-to-right" href="#">Papers</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Papers">Sources</a>
−
               <a class="hvr-sweep-to-right" href="#">Nucleic Acids</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/nucleic_acids">Nucleic Acids</a>
−
               <a class="hvr-sweep-to-right" href="#">Protocols</a>
+
               <a class="hvr-sweep-to-right" href="https://2020.igem.org/Team:Virginia/Protocols">Protocols</a>
−
              <a class="hvr-sweep-to-right" href="#">Software</a>
+
 
             </div>
 
             </div>
 
           </div>
 
           </div>
Line 117: Line 114:
 
       <div class="contentHolder">
 
       <div class="contentHolder">
 
           <div class="genTitle">
 
           <div class="genTitle">
−
             <div>General Template Page</div>
+
             <div>Parts</div>
 
           </div>
 
           </div>
−
           <div class="sectionTitle" id="Section 1">Section 1</div>
+
           <div class="sectionTitle" id="Section 1">Pandemic Parts and Lack Thereof</div>
 
           <div class="bar"></div>
 
           <div class="bar"></div>
 
           <div class="section">
 
           <div class="section">
 
             <div class="paragraph">
 
             <div class="paragraph">
−
                 The lack of a versatile and reliable way to improve metabolic flux channeling, pathway orthogonality, and product yields is a major impediment to the expanded utilization of biosynthesis for the production of drugs and industrially valuable chemicals. Manifold, a platform technology that addresses this problem, consists of <div class="dict">bacterial microcompartments<span><img src="https://upload.wikimedia.org/wikipedia/commons/thumb/2/25/Carboxysome_and_bacterial_microcompartments.jpg/800px-Carboxysome_and_bacterial_microcompartments.jpg"/>Bacterial microcompartments (BMCs) are organelle-like structures, consisting of a protein shell that encloses enzymes and other proteins. BMCs are typically about 40–200 nanometers in diameter and are entirely made of proteins. The shell functions like a membrane, as it is selectively permeable.</span></div> (BMCs) with encapsulated dsDNA scaffolds <div class="ref">[1]<span>Elbaz, J., Yin, P., &amp; Voigt, C. A. (2016). Genetic encoding of DNA nanostructures and their self-assembly in living bacteria. Nature communications, 7(1), 1-11.</span></div> that sequester and spatially organize, at fixed concentrations, biosynthetic enzymes presented as zinc-finger fusion proteins. Here we deliver the designs for an E. coli cell capable of synthesizing resveratrol using the Manifold platform. The Manifold platform will help lower costs and expand the applications of chemical biosynthesis. The lack of a versatile and reliable way to improve metabolic flux channeling, pathway orthogonality, and product yields is a major impediment to the expanded utilization of biosynthesis for the production of drugs and industrially valuable chemicals. Manifold, a platform technology that addresses this problem, consists of bacterial microcompartments (BMCs) with encapsulated dsDNA scaffolds that sequester and spatially organize, at fixed concentrations, biosynthetic enzymes presented as zinc-finger fusion proteins. Here we deliver the designs for an E. coli cell capable of synthesizing resveratrol using the Manifold platform. The Manifold platform will help lower costs and expand the applications of chemical biosynthesis.
+
                 The COVID-19 pandemic threw a wrench in the wet lab plans of the 2020 Virginia iGEM Team. While we were unable to get into the lab until September 8th and even then in a limited capacity, we did extensive work to plan our project including all the lab work needed to design a proof of concept for Manifold. Thus, although we have no parts to submit to the registry, we have design many parts which we are in the process of assembling. To see these parts and all of the nucleic acid sequences we have developed this year check out our <a href="https://2020.igem.org/Team:Virginia/nucleic_acids">Nucleic Acids</a> page.
−
            </div>
+
−
          </div>
+
−
          <div class="sectionTitle" id="Section 2">Section 2</div>
+
−
          <div class="bar"></div>
+
−
          <div class="section">
+
−
            <div class="paragraph">
+
−
              The invention consists of a protein shell comprising one or more proteins, one or more nucleic acid scaffolds of which there can be multiple copies, anabolic and/or catabolic enzymes specific to the desired biosynthesis pathway each containing a nucleic acid binding domain, recognition sequences for the utilized nucleic acid binding domains, nucleic acid spacers, and a linkage between the nucleic acid scaffolds and the protein shell. The protein shell (10) can take the form of any closed or open surface that comprises one or more repeating protein units (12). Examples of valid shells include bacterial microcompartments such as the Pdu, Eut, and carboxysome microcompartments, as well as modified,  but not necessarily closed, surfaces composed of mutated versions of these microcompartment shell proteins. The nucleic acid scaffolds (18) comprise multiple recognition sequences (22) and spacers (32) and can be made from any form of nucleic acid, including: deoxyribonucleic acid, ribonucleic acid, and synthetic nucleic acids such as xeno nucleic acids and peptide nucleic acids among others. These scaffolds are attached to the protein shell. The pathway enzymes are biological proteins whose exact sequences are dependent on the given use case of the invention, but which all contain a nucleic acid binding domain either internal to their structure, or at their N or C terminus.  
+
 
             </div>
 
             </div>
 
             <div class="figureHolder">
 
             <div class="figureHolder">
−
              <img src="https://static.igem.org/mediawiki/2019/3/31/T--NCKU_Tainan--CBMB-Amplification.png"/>
+
                <img src="https://static.igem.org/mediawiki/2020/e/e7/T--Virginia--images--bricks.svg"/>
−
              <div>
+
−
              <b>Fig 1.</b> Figure taken from iGEM Tainan 2019 for demo purposes. Notice how the figure is much longer than it is wide, and two images are coupled together to achive this. Try to do that as well so it looks good.
+
 
               </div>
 
               </div>
−
            </div>
 
−
            <div class="paragraph">
 
−
              Additionally, protein linkers are usually present between this nucleic acid binding domain and the enzyme structure to prevent inhibition of enzyme activity. However the exact linker(s) used,  if any, is(are) also dependent on the specific use case of the invention. These pathway enzymes are attached to the nucleic acid scaffolds via their nucleic acid binding domains. The nucleic acid recognition sequences (22) are unique or semi-unique sequences of nucleic acid monomers on the nucleic acid scaffolds to which the utilized nucleic acid binding domains have some degree of molecular complementarity. These nucleic recognition sequences comprise most of the scaffold and mark the locations to which the DNA binding domains of the pathway enzymes attach to the scaffolds. The nucleic acid spacers (32) are relatively short sequences of nucleic acid monomers that are also present on the nucleic acid scaffolds, between the recognition sequences. The linkage between the nucleic acid scaffolds (18) and protein shell (10) provides a means by which the nucleic acid scaffolds are bound to the protein shell through direct or multi-molecule complementarity. This linkage is found between the nucleic acid scaffolds and the protein shell. One example is through the addition of a nucleic acid binding domain (24) to one or more of the shell proteins forming a nucleic acid binding domain, shell protein fusion (14). Like the pathway enzymes, this nucleic acid binding-domain can be either internal to the shell protein structure or at its N or C terminus, where the exact placement depends on the shell protein being utilized. Alternatively, one or more intermediate proteins can be used to adhere the nucleic acid scaffolds to the shell, where the region of the protein interacting with the shell binds the shell via protein-protein complementarity (28) with a given shell protein, and the region of the protein interacting with the nucleic acid scaffold binds another recognition sequence on the nucleic acid scaffold through another nucleic acid binding domain (30). This forms a shell protein binding, nucleic acid domain fusion (26).<br/><br/><br/>
 
−
            </div>
 
 
           </div>
 
           </div>
 
       </div>
 
       </div>
Line 149: Line 133:
 
     <div class="footerholder">
 
     <div class="footerholder">
 
       <div class="bottomlogoholder">
 
       <div class="bottomlogoholder">
−
         <div class="logoring" id="logoring" onclick="window.scrollTo({ top: 0, behavior: 'smooth' })">
+
         <a class="logoring" href="#" id="logoring">
 
           <img id="animationImg" src="https://static.igem.org/mediawiki/2020/d/d8/T--Virginia--logo-up-frames--21.svg"/>
 
           <img id="animationImg" src="https://static.igem.org/mediawiki/2020/d/d8/T--Virginia--logo-up-frames--21.svg"/>
−
         </div>
+
         </a>
 
       </div>
 
       </div>
 
       <div class="footer">
 
       <div class="footer">
Line 157: Line 141:
 
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/d/d4/T--Virginia--sponsors--UVA.png"/></div>
 
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/d/d4/T--Virginia--sponsors--UVA.png"/></div>
 
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/c/c1/T--Virginia--sponsors--IDT.png"/></div>
 
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/c/c1/T--Virginia--sponsors--IDT.png"/></div>
−
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/c/c1/T--Virginia--sponsors--IDT.png"/></div>
+
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/4/41/T--Virginia--images--neb.png"/></div>
−
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/c/c1/T--Virginia--sponsors--IDT.png"/></div>
+
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/e/e6/T--Virginia--images--twist.png"/></div>
−
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/c/c1/T--Virginia--sponsors--IDT.png"/></div>
+
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/4/41/T--Virginia--images--cvillbiohub.png"/></div>
−
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/c/c1/T--Virginia--sponsors--IDT.png"/></div>
+
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/b/b8/T--Virginia--sponsors--addgene.png"/></div>
−
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/c/c1/T--Virginia--sponsors--IDT.png"/></div>
+
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/7/75/T--Virginia--sponsors--matlab.png"/></div>
−
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/c/c1/T--Virginia--sponsors--IDT.png"/></div>
+
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/9/96/T--Virginia--sponsors--Benchling.png"/></div>
−
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/c/c1/T--Virginia--sponsors--IDT.png"/></div>
+
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/6/69/T--Virginia--sponsors--qiagen.png"/></div>
−
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/c/c1/T--Virginia--sponsors--IDT.png"/></div>
+
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/f/f5/T--Virginia--sponsors--lucid.png"/></div>
 
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/d/dc/T--Virginia--sponsors--GenScript.png"/></div>
 
           <div class="sponsoritem hexagon"><img src="https://static.igem.org/mediawiki/2020/d/dc/T--Virginia--sponsors--GenScript.png"/></div>
 
         </div>
 
         </div>
Line 170: Line 154:
 
           <div class="menulogo">MANIFOLD</div>
 
           <div class="menulogo">MANIFOLD</div>
 
           <div class="followus">FOLLOW US:</div>
 
           <div class="followus">FOLLOW US:</div>
−
           <div class="sociallink"><div style="color:#7496D2;margin-right: 1em;">FACEBOOK:</div>@VIRGINIAiGEM2020</div>
+
           <div class="sociallink"><div style="color:#7496D2;margin-right: 1em;">EMAIL:</div> VAiGEM2020@GMAIL.COM</div>
 
           <div class="sociallink"><div style="color:#FF99FF;margin-right: 1em;">INSTAGRAM: </div>@iGEM.AT.UVA</div>
 
           <div class="sociallink"><div style="color:#FF99FF;margin-right: 1em;">INSTAGRAM: </div>@iGEM.AT.UVA</div>
−
           <div class="sociallink"><div style="color:#A3E7FF;margin-right: 1em;">TWITTER: </div>@VIRGINIAiGEM2020</div>
+
           <div class="sociallink"><div style="color:#A3E7FF;margin-right: 1em;">TWITTER: </div>@VIRGINIA_iGEM</div>
 
         </div>
 
         </div>
 
     </div>
 
     </div>
Line 178: Line 162:
 
     <!-- pre-load all images used in the animation to fix lag on the first run -->
 
     <!-- pre-load all images used in the animation to fix lag on the first run -->
 
     <div style="display: none;">
 
     <div style="display: none;">
 +
      <img src="https://static.igem.org/mediawiki/2020/8/81/T--Virginia--logo-up-frames--1.svg"/>
 
       <img src="https://static.igem.org/mediawiki/2020/1/17/T--Virginia--logo-up-frames--2.svg"/>
 
       <img src="https://static.igem.org/mediawiki/2020/1/17/T--Virginia--logo-up-frames--2.svg"/>
 
       <img src="https://static.igem.org/mediawiki/2020/9/95/T--Virginia--logo-up-frames--3.svg"/>
 
       <img src="https://static.igem.org/mediawiki/2020/9/95/T--Virginia--logo-up-frames--3.svg"/>

Latest revision as of 03:32, 28 October 2020

Manifold

HOME
Main Abstract
PROJECT
Description Design Experiments Results Modeling Engineering Implementation Notebook Safety
PARTS
Parts
OUTREACH
Human Practices Public Engagement Collaborations Contributions Entrepreneurship
TEAM
Members Attributions
AWARDS
Awards Medals
RESOURCES
Sources Nucleic Acids Protocols
Index:
Parts
Pandemic Parts and Lack Thereof
The COVID-19 pandemic threw a wrench in the wet lab plans of the 2020 Virginia iGEM Team. While we were unable to get into the lab until September 8th and even then in a limited capacity, we did extensive work to plan our project including all the lab work needed to design a proof of concept for Manifold. Thus, although we have no parts to submit to the registry, we have design many parts which we are in the process of assembling. To see these parts and all of the nucleic acid sequences we have developed this year check out our Nucleic Acids page.
FOLLOW US: